In summary, our study found that MT2A is expressed at low levels in CRC and correlates with M stage, and we demonstrated that MT2A mediates CRC cell proliferation and liver metastasis through the MST1/LATS2/YAP1 signaling pathway (Fig. 7). Here, LATS2 is linked to colorectal carcinoma.